Comparative assessment of late toxicity in patients of carcinoma cervix treated by radiotherapy versus chemo-radiotherapy – Minimum 5 years follow up

NIH News Advisory; NCI Issues Clinical Announcements on Cervical Cancer: Chemotherapy plus Radiation Therapy Improves Survival, 1999, 99. Rose, 1999, Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer, N. Engl. J. Med., 340, 1144, 10.1056/NEJM199904153401502 Morris, 1999, Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer, N. Engl. J. Med., 340, 1137, 10.1056/NEJM199904153401501 Peters, 2000, Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix, J. Clin. Oncol., 18, 1606, 10.1200/JCO.2000.18.8.1606 Keys, 1999, Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma, N. Engl. J. Med., 340, 1154, 10.1056/NEJM199904153401503 Whitney, 1999, Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjuvant to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study, J. Clin. Oncol., 17, 1339, 10.1200/JCO.1999.17.5.1339 Green, 2016, Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis, Lancet, 358, 781, 10.1016/S0140-6736(01)05965-7 Lukka, 2002, Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer – a meta-analysis, Clin. Oncol., 14, 203, 10.1053/clon.2002.0076 Datta, 2017, Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervixcancer: a systematic review and meta-analysis, Gynecol. Oncol., 145, 374, 10.1016/j.ygyno.2017.01.033 2001, Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis, Cochrane Database Syst. Rev., 1, CD008285 Maduro, 2003, Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer, Cancer Treat. Rev., 29, 471, 10.1016/S0305-7372(03)00117-8 Kirwan, 2003, A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer, Radiother. Oncol., 68, 217, 10.1016/S0167-8140(03)00197-X Pecorelli, 1999, FIGO staging of gynecologic cancer, Int. J. Gynecol. Obstet., 64, 5, 10.1016/S0020-7292(98)00234-3 Chassagne, 1985 Cox, 2005, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC), Int. J. Radiat. Oncol. Biol. Phys., 31, 1341, 10.1016/0360-3016(95)00060-C Carde, 1981, Effect of cis-dichlorodiammine platinum II and X rays on mammalian cell survival, Int. J. Radiat. Oncol. Biol. Phys., 7, 929, 10.1016/0360-3016(81)90011-0 Wallner, 1987, Effect of cisplatin resistance on cellular radiation response, Int. J. Radiat. Oncol. Biol. Phys., 13, 587, 10.1016/0360-3016(87)90076-9 Peters, 1995, Complicating issues in complication reporting, Int. J. Radiat. Oncol. Biol. Phys., 31, 1349, 10.1016/0360-3016(95)00041-V Caplan, 1994, Analysis of the probability and risk of cause-specific failure, Int. J. Radiat. Oncol. Biol. Phys., 29, 1183, 10.1016/0360-3016(94)90416-2 Bentzen, 1995, Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment … now!, Int. J. Radiat. Oncol. Biol. Phys., 32, 1531, 10.1016/0360-3016(95)00262-W Pedersen, 1993, Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification system, Radiother. Oncol., 28, 134, 10.1016/0167-8140(93)90005-S Eifel, 1995, Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix, Int. J. Radiat. Oncol. Biol. Phys., 32, 10.1016/0360-3016(95)00118-I Pearcey, 2002, Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix, J. Clin. Oncol., 20, 966, 10.1200/JCO.2002.20.4.966 Pedersen, 1994, Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of cervix, Int. J. Radiat. Oncol. Biol. Phys., 29, 941, 10.1016/0360-3016(94)90387-5 Tan, 2008, Long-term survival and late toxicity after chemoradiotherapy for cervical cancer; the Addenbrooke's experience, Clin. Oncol., 20, 358, 10.1016/j.clon.2008.03.001 Lanciano, 1992, Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A patterns of care study, Cancer, 69, 2124, 10.1002/1097-0142(19920415)69:8<2124::AID-CNCR2820690819>3.0.CO;2-D Ferrigno, 2003, Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables, Int. J. Radiat. Oncol. Biol. Phys., 55, 695, 10.1016/S0360-3016(02)03939-1 Saibishkumar, 2005, Results of a phase II trial of concurrent chemoradiation in the treatment of locally advanced carcinoma of uterine cervix: an experience from India, Bull. Cancer, 92, E7 King, 2006, Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects, Clin. Oncol. (R Coll. Radiol.), 18, 38, 10.1016/j.clon.2005.09.001 Tseng, 1997, A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix, Gynecol. Oncol., 66, 52, 10.1006/gyno.1997.4721 Wong, 1999, Chemoradiation and adjuvant chemotherapy in cervical cancer, J. Clin. Oncol., 17, 2055, 10.1200/JCO.1999.17.7.2055 Hongwei, 1997, The effect of randomized trial of hyperthermo-radiochemotherapy for carcinoma of the cervix, Chin. J. Oncol., 24, 249 Eifel, 2004, Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group Trial (RTOG) 90-01, J. Clin. Oncol., 22, 872, 10.1200/JCO.2004.07.197 Spensley, 2009, Clinical outcome for chemoradiotherapy in carcinoma of the cervix, Clin. Oncol. (R. Coll. Radiol.), 21, 49, 10.1016/j.clon.2008.10.014 Georg, 2013, Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancer, Strahlenther. Onkol., 189, 535, 10.1007/s00066-013-0365-7 Marks, 1995, The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy, Int. J. Radiat. Oncol. Biol. Phys., 31, 1257, 10.1016/0360-3016(94)00431-J Gondi, 2012, Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis, Int. J. Radiat. Oncol. Biol. Phys., 84, 973, 10.1016/j.ijrobp.2012.01.064 Miles, 2014, Vaginal dilator therapy for women receiving pelvic radiotherapy, Cochrane Database Syst. Rev., CD007291 Schmeler, 2010, Pelvic fractures after radiotherapy for cervical cancer: implications for survivors, Cancer, 116, 625, 10.1002/cncr.24811 Grigsby, 1995, Femoral neck fracture following groin irradiation, Int. J. Radiat. Oncol. Biol. Phys., 32, 63, 10.1016/0360-3016(95)00546-B Oh, 2008, Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: analysis of risk factors, Int. J. Radiat. Oncol. Biol. Phys., 70, 1183, 10.1016/j.ijrobp.2007.08.005 Ogino, 2003, Pelvic insufficiency fractures in postmenopausal woman with advanced cervical cancer treated by radiotherapy, Radiother. Oncol., 68, 61, 10.1016/S0167-8140(03)00128-2 Ikushima, 2006, Pelvic bone complications following radiation therapy of gynecologic malignancies: clinical evaluation of radiation-induced pelvic insufficiency fractures, Gynecol. Oncol., 103, 1100, 10.1016/j.ygyno.2006.06.038 Hopewell, 2003, Radiation-therapy effects on bone density, Med. Pediatr. Oncol., 41, 208, 10.1002/mpo.10338 Vale, 2010, Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists' audit, Clin. Oncol. (R. Coll. Radiol.), 22, 590, 10.1016/j.clon.2010.06.002 Perez, 1984, Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications, Cancer, 54, 235, 10.1002/1097-0142(19840715)54:2<235::AID-CNCR2820540210>3.0.CO;2-H Kleinerman, 1995, Second primary cancer after treatment for cervical cancer. An international cancer registries study, Cancer, 76, 442, 10.1002/1097-0142(19950801)76:3<442::AID-CNCR2820760315>3.0.CO;2-L Perez, 1999, Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation, Int. J. Radiat. Oncol. Biol. Phys., 44, 855, 10.1016/S0360-3016(99)00111-X Montana, 1985, Analysis of results of radiation therapy for Stage II carcinoma of the cervix, Cancer, 55, 956, 10.1002/1097-0142(19850301)55:5<956::AID-CNCR2820550507>3.0.CO;2-V Clark, 1994, Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis, Int. J. Radiat. Oncol. Biol. Phys., 28, 1243, 10.1016/0360-3016(94)90501-0 Nag, 2000, The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix, Int. J. Radiat. Oncol. Biol. Phys., 48, 201, 10.1016/S0360-3016(00)00497-1 Bajpai, 2008, Defining the standard of care;waiting times, data recording. adverse effects reporting, radiotherapy compliance and follow up of head and neck cancer patients, at a tertiary care center in India, Int. J. Radiat. Oncol. Biol. Phys., 72, S412, 10.1016/j.ijrobp.2008.06.1312 Kirchheiner, 2012, Do clinicians and patients agree regarding symptoms? A comparison after definitive radiochemotherapy in 223 uterine cervical cancer patients, Strahlenther. Onkol., 188, 933, 10.1007/s00066-012-0156-6 Schmid, 2012, Late gastrointestinal and urogenital side-effects after radiotherapy--incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer, Radiother. Oncol., 104, 114, 10.1016/j.radonc.2012.05.007 Davidson, 2007, Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency, Int. J. Radiat. Oncol. Biol. Phys., 69, 1218, 10.1016/j.ijrobp.2007.04.054